These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The second wave in kinase cancer drugs. Garber K Nat Biotechnol; 2006 Feb; 24(2):127-30. PubMed ID: 16465146 [No Abstract] [Full Text] [Related]
8. Sugen falls as casualty of Pfizer-Pharmacia merger. Garber K Nat Biotechnol; 2003 Jul; 21(7):722-3. PubMed ID: 12833079 [No Abstract] [Full Text] [Related]
9. A very firm handshake: biotech's growing negotiating power. Thiel KA Nat Biotechnol; 2005 Oct; 23(10):1221-6. PubMed ID: 16211058 [No Abstract] [Full Text] [Related]
10. Glyn Edwards talks about cancer drug development at Antisoma. Interview by Ulrike Knies-Bamforth and Dan Huke. Edwards G Drug Discov Today; 2005 Nov; 10(22):1491-4. PubMed ID: 16257369 [TBL] [Abstract][Full Text] [Related]
18. Are the large pharmaceutical and biotechnology companies driving the discovery, research and development of targeted cancer therapies? Gallant GJ Future Med Chem; 2012 Jan; 4(1):13-7. PubMed ID: 22168161 [No Abstract] [Full Text] [Related]